Repotrectinib, a promising targeted therapy, has shown significant tumor reduction in patients with ROS1-positive non-small cell lung cancer (NSCLC). This...
Novocure, a global oncology company specializing in the development of innovative cancer therapies, has recently submitted a Premarket Approval (PMA)...
Darmiyan’s Brain Test Receives FDA Approval in Recognition of Alzheimer’s Awareness Month In a significant development for the field of...
Title: FDA Approves Sickle Cell Drug for Treatment of Additional Blood Disorder – Comprehensive Update from Drugs.com MedNews Introduction In...
The Crucial Role of Statistical Programmers in the FDA Approval of Vaccines When it comes to the development and approval...
Understanding Clinical Data Standardization in Clinical Trials and its Importance for FDA Compliance: Insights from ProRelix Research Clinical trials play...
Sequana Medical, a Swiss medical device company, is currently seeking approval from the US Food and Drug Administration (FDA) for...
Cellusion’s CLS001 Granted Orphan Drug Designation by U.S. FDA, Reports Drugs.com MedNews In a significant development for the pharmaceutical industry,...
Inspection Findings at Third-Party Manufacturer Prompt U.S. Food and Drug Administration’s Complete Response Letter for Cosibelimab The U.S. Food and...
LUMA Vision, a leading medical technology company, has recently announced securing $22 million in funding to further develop its groundbreaking...
FDA Expands Approval for Merck’s $1B Cancer Drug to Treat Wider Range of Patients The U.S. Food and Drug Administration...
CymaBay Therapeutics, a biopharmaceutical company focused on developing innovative therapies for liver and metabolic diseases, has recently announced its submission...
The FDA eSTAR Submission Template is an essential tool for companies seeking to gain approval for their medical devices or...
The California Institute for Regenerative Medicine (CIRM) recently released a statement regarding the U.S. Food and Drug Administration’s (FDA) approval...
MAPS (Multidisciplinary Association for Psychedelic Studies) has recently submitted an application to the U.S. Food and Drug Administration (FDA) seeking...
